⏳ Fetching live dividend data...
Home › Calculator › GNBT Dividend Calculator 2026
Generex Biotechnology Corporation · OTC
Price: $0.00 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
GNBT is not a dividend-focused stock
GNBT pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Generex Biotechnology Corporation (GNBT) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
Founded in 1983 and headquartered in Miramar, Florida, Generex Biotechnology Corporation initially specialized in the delivery of large molecule drugs into the oral cavity via a portable aerosol applicator for use in Canada and the United States, notably offering Generex Oral-lyn, an oral insulin product. The company also had a significant focus on oncology, developing AE37, a synthetic peptide vaccine that had completed Phase IIb clinical trials aimed at stimulating a potent and specific immune response against HER-2/neu oncogenes in breast and prostate cancer patients. Beyond therapeutics, Generex was involved in the development, manufacturing, and distribution of rapid point-of-care in-vitro medical diagnostics for a spectrum of infectious diseases, including HIV, tuberculosis, malaria, and hepatitis, providing both test kits and cassettes. Its product portfolio further included Excellagen, a wound-conforming gel. The company's research and development efforts also extended to immunotherapeutic products, additional vaccines, and an extracellular matrix hydrogel solution designed for the treatment of Ulcerative Colitis. In addition, Generex manufactured and sold specialized surgical kits for foot and ankle procedures, containing plates, screws, and tools, and distributed a wide array of surgical supplies, orthopedic implants, artificial joints, biologics, medical devices, and regenerative medicine products. The corporation also acted as the general partner for a Management Services Organization. However, on April 23, 2022, an involuntary petition for Chapter 7 liquidation was filed against Generex Biotechnology Corporation in the U.S. Bankruptcy Court for the Southern District of Florida, which was subsequently approved by the court on June 6, 2022.
No. Generex Biotechnology Corporation (GNBT) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
A DRIP reinvests dividends into new shares. GNBT has no regular dividend in our data, so there is nothing to reinvest.
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open GNBT position with:
Real after-tax yield depends on where you live and how you hold GNBT.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
GNBT pays quarterly — 4 times per year. Ex-div: —.
How GNBT compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for GNBT sourced from FMP /financial-growth endpoint — real data, not estimates.
Compare GNBT with peers: GNBT vs ALEAF · GNBT vs CRXTQ · GNBT vs ENDP
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the GNBT dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Generex Biotechnology Corporation (GNBT) is currently trading at $0.00, trading near its 52-week low. It does not currently pay a regular dividend.
Generex Biotechnology Corporation (GNBT) is a healthcare stock trading at $0.00. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
Auto-generated from live market data. For educational purposes only — not financial advice.
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever